MALT1 and autoimmune disease: While this view is supported by several preclinical studies using MALT1 PD animals or tool MALT1 inhibitors, the spontaneous multi-organ autoimmune disease that develops in MALT1 PD animals has raised concerns about the safety of pharmacological inhibition of the MALT1 protease.